| RS1064797171 |
CEP290
|
Health Risk |
Likely pathogenic |
— |
| RS1064797173 |
WASHC4
|
Health Risk |
Likely pathogenic |
— |
| RS1064797177 |
EDNRB
|
Health Risk |
Likely pathogenic |
Hearing impairment, Hearing impairment |
| RS1064797178 |
EDNRB
|
Health Risk |
Pathogenic |
— |
| RS1064797180 |
COL4A2
|
Health Risk |
Likely pathogenic |
— |
| RS1064797182 |
RPGRIP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Leber congenital amaurosis 6, Leber congenital amaurosis |
| RS1064797183 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1064797184 |
MYH7
|
Health Risk |
Likely pathogenic |
— |
| RS1064797186 |
FOXG1
|
Health Risk |
Likely pathogenic |
FOXG1 disorder, FOXG1 disorder |
| RS1064797188 |
SYNE2
|
Health Risk |
Likely pathogenic |
— |
| RS1064797192 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Charcot-Marie-Tooth disease axonal type 2O |
| RS1064797196 |
SNHG14;UBE3A
|
Health Risk |
Likely pathogenic |
— |
| RS1064797202 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
POLG-related disorder, POLG-related disorder |
| RS1064797205 |
PKD1
|
Health Risk |
Likely pathogenic |
Autosomal dominant polycystic kidney disease, Polycystic kidney disease |
| RS1064797209 |
MYH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 4 |
| RS1064797211 |
GNAO1
|
Health Risk |
Likely pathogenic |
— |
| RS1064797215 |
PRPF8
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 13 |
| RS1064797217 |
GUCY2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 1, Cone-rod dystrophy 6 |
| RS1064797218 |
MYO15A
|
Health Risk |
Likely pathogenic |
— |
| RS1064797219 |
CRYBA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cataract 10 multiple types, Cataract 10 multiple types |
| RS1064797229 |
RAC3
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with structural brain anomalies and dysmorphic facies, See cases |
| RS1064797230 |
MICOS13
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation deficiency 37, Combined oxidative phosphorylation deficiency 37 |
| RS1064797231 |
TUBB4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Torsion dystonia 4, Torsion dystonia 4 |
| RS1064797234 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1064797235 |
C19orf12
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodegeneration with brain iron accumulation 4, Neurodegeneration with brain iron accumulation 4 |
| RS1064797237 |
WDR62
|
Health Risk |
Likely pathogenic |
— |
| RS1064797239 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS1064797242 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS1064797243 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS1064797244 |
PRX
|
Health Risk |
Likely pathogenic |
— |
| RS1064797245 |
ATP1A3
|
Health Risk |
Likely pathogenic |
Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Dystonia 12 |
| RS1064797246 |
CRX
|
Health Risk |
Pathogenic/Likely pathogenic |
Cone-rod dystrophy 2, Leber congenital amaurosis 7 |
| RS1064797247 |
CRX
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Cone-rod dystrophy 2 |
| RS1064797248 |
PPP2R1A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1064797250 |
PRPF31;PRPF31-AS1
|
Health Risk |
Likely pathogenic |
— |
| RS1064797253 |
DYSF
|
Health Risk |
Likely pathogenic |
— |
| RS1064797257 |
REEP1
|
Health Risk |
Likely pathogenic |
Glioma susceptibility 1, Glioma susceptibility 1 |
| RS1064797258 |
CNGA3
|
Health Risk |
Likely pathogenic |
— |
| RS1064797263 |
SCN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 11 |
| RS1064797265 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1064797266 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS1064797269 |
ABCB11
|
Health Risk |
Likely pathogenic |
— |
| RS1064797270 |
ABCB11
|
Health Risk |
Pathogenic |
Benign recurrent intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |
| RS1064797276 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiomyopathy |
| RS1064797278 |
CERKL
|
Health Risk |
Conflicting classifications of pathogenicity |
Isolated macular dystrophy, Retinal dystrophy |
| RS1064797281 |
ALS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Juvenile primary lateral sclerosis, Amyotrophic lateral sclerosis type 2 |
| RS1064797284 |
KCNQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS1064797285 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1064797289 |
SHANK3
|
Health Risk |
Likely pathogenic |
— |
| RS1064797290 |
SHANK3
|
Health Risk |
Likely pathogenic |
— |
| RS1064797291 |
RAF1
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, RASopathy |
| RS1064797294 |
MITF
|
Health Risk |
Likely pathogenic |
Waardenburg syndrome, Waardenburg syndrome |
| RS1064797302 |
OPA1
|
Health Risk |
Likely pathogenic |
— |
| RS1064797303 |
OPA1
|
Health Risk |
Likely pathogenic |
Optic atrophy, Optic atrophy |
| RS1064797304 |
PDE6B
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 40, Leber congenital amaurosis |
| RS1064797306 |
WFS1
|
Health Risk |
Likely pathogenic |
Wolfram syndrome 1, Wolfram syndrome 1 |
| RS1064797310 |
MEF2C
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia, stereotypic hand movements |
| RS1064797311 |
NR2F1
|
Health Risk |
Likely pathogenic |
Seizure, Seizure |
| RS1064797314 |
SH3TC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4C |
| RS1064797315 |
PDE6A
|
Health Risk |
Likely pathogenic |
— |
| RS1064797316 |
GLRA1
|
Health Risk |
Likely pathogenic |
— |
| RS1064797322 |
SYNGAP1
|
Health Risk |
Likely pathogenic |
SYNGAP1-related disorder, Intellectual disability |
| RS1064797324 |
EYS
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1064797325 |
COL9A1
|
Health Risk |
Likely pathogenic |
— |
| RS1064797326 |
COL12A1
|
Health Risk |
Likely pathogenic |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS1064797327 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS1064797328 |
LAMA2
|
Health Risk |
Likely pathogenic |
— |
| RS1064797331 |
SYNE1
|
Health Risk |
Likely pathogenic |
— |
| RS1064797332 |
SYNE1
|
Health Risk |
Likely pathogenic |
— |
| RS1064797336 |
HSPB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1064797337 |
COL1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS1064797339 |
SGCE
|
Health Risk |
Pathogenic/Likely pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS1064797344 |
THAP1
|
Health Risk |
Likely pathogenic |
Torsion dystonia 6, Torsion dystonia 6 |
| RS1064797347 |
CSPP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 21, Joubert syndrome 21 |
| RS1064797348 |
GRHL2
|
Health Risk |
Likely pathogenic |
— |
| RS1064797350 |
PLEC
|
Health Risk |
Likely pathogenic |
— |
| RS1064797351 |
FREM1
|
Health Risk |
Likely pathogenic |
BNAR syndrome, Trigonocephaly 2 |
| RS1064797355 |
GRIN1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS1064797360 |
CDKL5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1064797362 |
ARX
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS1064797363 |
RPGR
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1064797364 |
RPGR
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1064797365 |
RPGR
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 3 |
| RS1064797366 |
RPGR
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinitis pigmentosa |
| RS1064797368 |
RP2
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1064797369 |
SYN1
|
Health Risk |
Likely pathogenic |
— |
| RS1064797371 |
CACNA1F
|
Health Risk |
Pathogenic/Likely pathogenic |
Aland island eye disease, Colon adenocarcinoma |
| RS1064797373 |
OPHN1
|
Health Risk |
Likely pathogenic |
— |
| RS1064797376 |
PCDH19
|
Health Risk |
Likely pathogenic |
— |
| RS1064797377 |
PCDH19
|
Health Risk |
Likely pathogenic |
— |
| RS1064797380 |
EMD
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked Emery-Dreifuss muscular dystrophy, Cardiovascular phenotype |
| RS1064797381 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1064797382 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS1064975 |
ADAMTSL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Geleophysic dysplasia 1, Geleophysic dysplasia 1 |
| RS1065671 |
TUBA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1065746 |
HTT
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1065747 |
HTT
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1065761 |
CHIT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Chitotriosidase deficiency, Chitotriosidase deficiency |
| RS10687343 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS10754555 |
NLRP3
|
Health Risk |
Likely risk allele |
Long COVID-19, Long COVID-19 |